Jim Simons Ardelyx, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ardelyx, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,301,193 shares of ARDX stock, worth $6.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,301,193

Previous 1,351,593 3.73%

Holding current value

$6.87 Million

Previous $6.64 Million 23.15%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$3.28 - $5.51 $165,312 - $277,704	-50,400 Reduced 3.73%	1,301,193 $5.1 Million
Q1 2025 May 14, 2025	BUY	$4.91 - $6.36 $6.64 Million - $8.6 Million	1,351,593 New	1,351,593 $6.64 Million
Q3 2023 Nov 14, 2023	SELL	$3.3 - $4.83 $2.18 Million - $3.2 Million	-661,720 Reduced 35.83%	1,185,273 $4.84 Million
Q2 2023 Aug 11, 2023	SELL	$3.23 - $4.95 $4.17 Million - $6.39 Million	-1,290,700 Reduced 41.14%	1,846,993 $6.26 Million
Q1 2023 May 12, 2023	BUY	$2.68 - $4.79 $7.2 Million - $12.9 Million	2,688,000 Added 597.74%	3,137,693 $15 Million
Q4 2022 Feb 13, 2023	BUY	$1.22 - $2.85 $238,441 - $557,015	195,444 Added 76.87%	449,693 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $26,701 - $65,168	45,256 Added 21.65%	254,249 $303,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $1.17 $554,166 - $1.27 Million	-1,086,600 Reduced 83.87%	208,993 $123,000
Q1 2022 May 13, 2022	SELL	$0.65 - $1.18 $484,138 - $878,897	-744,828 Reduced 36.5%	1,295,593 $1.39 Million
Q4 2021 Feb 11, 2022	BUY	$0.86 - $1.7 $1.75 Million - $3.47 Million	2,040,421 New	2,040,421 $2.24 Million
Q2 2021 Aug 13, 2021	SELL	$6.55 - $8.98 $3.27 Million - $4.48 Million	-499,273 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$6.1 - $7.69 $1.61 Million - $2.03 Million	-263,594 Reduced 34.55%	499,273 $3.31 Million
Q4 2020 Feb 10, 2021	SELL	$5.05 - $7.1 $1.54 Million - $2.17 Million	-304,947 Reduced 28.56%	762,867 $4.94 Million
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $3.26 Million - $4.4 Million	-621,520 Reduced 36.79%	1,067,814 $5.61 Million
Q2 2020 Aug 13, 2020	SELL	$5.37 - $8.11 $1.6 Million - $2.42 Million	-298,000 Reduced 14.99%	1,689,334 $11.7 Million
Q1 2020 May 14, 2020	SELL	$4.35 - $8.79 $2.07 Million - $4.18 Million	-475,900 Reduced 19.32%	1,987,334 $11.3 Million
Q4 2019 Feb 13, 2020	BUY	$4.23 - $8.29 $131,553 - $257,818	31,100 Added 1.28%	2,463,234 $18.5 Million
Q3 2019 Nov 13, 2019	BUY	$2.15 - $6.28 $713,937 - $2.09 Million	332,064 Added 15.81%	2,432,134 $11.4 Million
Q2 2019 Aug 12, 2019	BUY	$2.49 - $3.73 $294,985 - $441,885	118,468 Added 5.98%	2,100,070 $5.65 Million
Q1 2019 May 14, 2019	SELL	$1.88 - $3.35 $408,183 - $727,348	-217,119 Reduced 9.87%	1,981,602 $5.55 Million
Q4 2018 Feb 13, 2019	BUY	$1.66 - $4.16 $3.65 Million - $9.15 Million	2,198,721 New	2,198,721 $3.94 Million

Others Institutions Holding ARDX

# of Institutions

222

Shares Held

167M

Call Options Held

517K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $816M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account